Bexson Biomedical is a biopharmaceutical company focused on delivering small molecules subcutaneously with our SeValent™ technology, to enable home health delivery.
We are initially focused on addressing the opioid crisis by developing our BB106 non-opioid therapy for acute pain management.
Partnering with the Stevanato Group, we are creating the first modular, pre-filled, and pre-sterilized subcutaneous pump that can be utilized to deliver hundreds of drugs.Learn More
Modular science which optimizes pH, osmolality, and volume making subcutaneous delivery possible and improving pharmacokinetics for non-subcutaneous drugs.Learn More
A dynamic programmable drug delivery platform that can be repurposed for various drugs.Learn More